Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EmbryoGlue in Repeated Implantation Failure (RIF) Patients
NCT04709796Recruiting
- Sponsor
- Ghent University Hospital
- Start
- Mar 2021
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of EmbryoGlue in Repeated Implantation Failure (RIF) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Live birth at 9 months. Started Mar 2021; status: recruiting.
02
Drugs
EmbryoGlue
03
Conditions
Repeated Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT04709796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709796.